Delnova
The biopharmaceutical company specializes in life cycle management for botulinum toxin therapies, focusing on complications that arise from these treatments. By utilizing clinically validated molecules and repurposed drugs, the company provides targeted drug delivery solutions to enhance therapeutic outcomes.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$810KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The biopharmaceutical company specializes in life cycle management for botulinum toxin therapies, focusing on complications that arise from these treatments. By utilizing clinically validated molecules and repurposed drugs, the company provides targeted drug delivery solutions to enhance therapeutic outcomes.